Suppr超能文献

一种用于治疗高血压急症的口服钙拮抗剂。

An oral calcium antagonist for treatment of hypertensive emergencies.

作者信息

Conen D, Bertel O, Dubach U C

出版信息

J Cardiovasc Pharmacol. 1982;4 Suppl 3:S378-82.

PMID:6184572
Abstract

The efficacy and safety of 20 mg of nifedipine as a single oral dose have been studied with respect to the use of the drug as an alternative treatment of hypertensive emergencies. The study population consisted of nine male and nine female patients, 47 to 80 years old. The mean systolic blood pressure decreased from 220 +/- 22 to 150 +/- 21 mm Hg and the mean diastolic blood pressure from 122 +/- 11 to 86 +/- 10 mm Hg (p less than 0.001) within 20-30 min. The decrease of blood pressure was paralleled by a small but significant increase (p less than 0.01) in heart rate from 74 +/- 9 to 85 +/- 10 beats/min. The fall of blood pressure was directly related to pretreatment values. Oral nifedipine can be recommended as a first-line drug to lower blood pressure in hypertensive emergencies.

摘要

就硝苯地平20毫克单次口服剂量作为高血压急症替代治疗药物的使用情况,对其疗效和安全性进行了研究。研究对象包括9名男性和9名女性患者,年龄在47至80岁之间。在20至30分钟内,平均收缩压从220±22毫米汞柱降至150±21毫米汞柱,平均舒张压从122±11毫米汞柱降至86±10毫米汞柱(p<0.001)。血压下降的同时,心率从74±9次/分钟小幅但显著增加至85±10次/分钟(p<0.01)。血压下降与治疗前的值直接相关。口服硝苯地平可推荐作为高血压急症降血压的一线药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验